Curated Wealth Partners LLC reduced its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 98.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,266 shares of the company’s stock after selling 926,545 shares during the quarter. Curated Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $1,132,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. TD Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 61.4% during the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after purchasing an additional 124 shares in the last quarter. Virginia Estate & Retirement Planning Advisors Inc. raised its stake in Colgate-Palmolive by 1,409.1% in the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after buying an additional 310 shares in the last quarter. Parvin Asset Management LLC bought a new position in Colgate-Palmolive in the second quarter worth about $32,000. Park Place Capital Corp lifted its holdings in Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock worth $33,000 after buying an additional 127 shares during the period. Finally, Gould Capital LLC lifted its holdings in Colgate-Palmolive by 38.7% in the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after buying an additional 115 shares during the period. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Up 0.1%
NYSE CL traded up $0.13 during trading hours on Thursday, reaching $92.91. 3,520,743 shares of the company’s stock traded hands, compared to its average volume of 5,659,334. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The firm has a 50-day simple moving average of $89.04 and a 200 day simple moving average of $88.93. The firm has a market cap of $74.06 billion, a PE ratio of 36.86, a PEG ratio of 4.30 and a beta of 0.33.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s payout ratio is presently 84.13%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on CL shares. Evercore upped their target price on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Morgan Stanley reissued an “overweight” rating and issued a $104.00 target price (up from $100.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. BNP Paribas Exane dropped their price target on Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, September 28th. Raymond James Financial lifted their price target on Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, September 8th. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $97.95.
Get Our Latest Analysis on Colgate-Palmolive
Insider Buying and Selling at Colgate-Palmolive
In other news, Director John Cahill sold 4,170 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Noel Wallace sold 161,021 shares of the firm’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is owned by insiders.
Colgate-Palmolive Profile
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
See Also
- Five stocks we like better than Colgate-Palmolive
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
